CHARACTERISTICS OF THE CHRONIC HEART FAILURE COURSE AND TARGET ORGAN CONDITION IN CARDIORENAL SYNDROME
https://doi.org/10.15829/1560-4071-2018-1-21-26
Abstract
Aim. To investigate on the specifics of chronic heart failure (CHF) course and functional remodeling of target organs in coronary heart disease (CHD) patients with chronic renal disease (CRD).
Material and methods. According to the criteria, 162 patients included, with CHD and CHF II-III functional class (FC), selected to 2 equal groups: group 1 — CRD patients, group 2 — with no renal dysfunction. For comparison, the parameters were evaluated that represent the specifics of CHF pathogenesis, structural and functional condition of the left heart chambers, of arteries and kidneys.
Results. The presence of CRD was related to more serious diastolic dysfunction in CHD with CHF patients (p<0,001 for E/e’ and mean e’) and increase of the left ventricle myocardial mass index (p=0,0043) and preserved ejection fraction of the left ventricle (p<0,001), followed by higher level of N-terminal natriuretic peptide (p=0,018). More significant filtration disorders of kidneys (p<0,001 for all values) with no progression of tubular disorders (p=0,078), more prominent arterial stiffness (p<0,001 by index CAVI1 and augmentation index) with the increase of TIMP-1 (p=0,002) registered in CHD with CHF plus CRD patients.
Conclusion. With CRD, there is more serious CHF with preserved LV EF and diastolic dysfunction. Target organ remodeling in CHD and CHF with CRD patients was characterized by some specific regularities of structural and functional condition of the heart, of arterial vessels and kidneys, and of one of the mechanisms there was a disordered balance of collagenolysis towards risk of fibrosis.About the Authors
I. I. KolegovaRussian Federation
A. I. Chernyavina
Russian Federation
N. A. Koziolova
Russian Federation
References
1. Ronco C, McCullough P, Anker SD, et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31 (6): 703-11. DOI: 10.1093/eurheartj/ehp507
2. De Vecchis R, Baldi C. Cardiorenal syndrome type 2: from diagnosis to optimal management. Ther Clin Risk Manag. 2014; 10: 949-61. DOI: 10.2147/TCRM.S63255.
3. Ishigami J, Grams ME, Naik RP, et al. Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2018; 7 (2). pii: e007209. DOI: 10.1161/JAHA.117.007209.
4. Duni A, Liakopoulos V, Rapsomanikis KP, Dounousi E. Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? Oxid Med Cell Longev. 2017; 2017: 9036450. DOI: 10.1155/2017/9036450.
5. Carubelli V, Metra M, Lund LH. Negotiating renal dysfunction when treating patients with heart failure. Expert Rev Cardiovasc Ther. 2018; 16 (2): 113-22. DOI: 0.1080/14779072.2018.1422178.
6. Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014; 64 (21): 2281-93. DOI: 10.1016/j.jacc.2014.08.036.
7. Rutherford E, Mark PB. What happens to the heart in chronic kidney disease? J R Coll Physicians Edinb. 2017; 47 (1): 76-82. DOI: 10.4997/JRCPE.2017.117.
8. Kadappu KK, Abhayaratna K, Boyd A, et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic KidneyDisease: The Value of Left Atrial Function and Volume. J Am Soc Echocardiogr. 2016; 29 (4): 359-67. DOI: 10.1016/j.echo.2015.11.019.
9. Sedaghat S, Mattace-Raso FU, Hoorn EJ, et al. Arterial Stiffness and Decline in Kidney Function. Clin J Am Soc Nephrol. 2015; 10 (12): 2190-7. DOI: 10.2215/CJN.03000315.
10. Kousios A, Kouis P, Panayiotou AG. Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int J Nephrol. 2016; 2016:9498013. DOI: 10.1155/2016/9498013.
11. Wang F, Xiong R, Feng S. Association of Circulating Levels of ADMA with Carotid IntimaMedia Thickness in Patients with CKD: a Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2018 Jan 23; 43 (1): 25-33. DOI: 10.1159/000486743.
12. Medić B, Rovčanin B, Basta Jovanović G, et al. Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Biomed Res Int. 2015; 2015:854070. DOI: 10.1155/2015/854070.
13. Brankovic M, Akkerhuis KM, van Boven N, et al. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study. Kidney Int. 2017. pii: S0085-2538(17)30729-9. DOI: 10.1016/j.kint.2017.09.013.
14. Zhou LT, Lv LL, Pan MM, et al. Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis. PLoS One. 2016; 11 (12): e0167334. DOI: 10.1371/journal.pone.0167334.
Review
For citations:
Kolegova I.I., Chernyavina A.I., Koziolova N.A. CHARACTERISTICS OF THE CHRONIC HEART FAILURE COURSE AND TARGET ORGAN CONDITION IN CARDIORENAL SYNDROME. Russian Journal of Cardiology. 2018;(1):21-26. (In Russ.) https://doi.org/10.15829/1560-4071-2018-1-21-26